NVO Novo-Nordisk A/S
- 125.790
- -0.370-0.29%
- 125.480
- -0.310-0.25%
Novo-Nordisk A/S News
6-K: Articles of Association of Novo Nordisk A/S
6-K: Novo Nordisk A/S – Reduction of the Share Capital
Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme
Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme
Novo-Nordisk A/S | 6-K: Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons
Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme
Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme
Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme
Novo-Nordisk A/S | 6-K: Articles of Association of Novo Nordisk A/S
Novo-Nordisk A/S | 6-K: Awiqli® (Once-Weekly Basal Insulin Icodec) Recommended for Approval for the Treatment of Diabetes by the European Regulatory Authorities
Novo-Nordisk A/S | 6-K: Resolutions from the Annual General Meeting of Novo Nordisk A/S
Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme
Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme
Novo-Nordisk A/S | 6-K: Wegovy® Approved in the Us for Cardiovascular Risk Reduction in People with Overweight or Obesity and Established Cardiovascular Disease
Novo-Nordisk A/S | 6-K: Novo Nordisk Announced the Headline Results from the Kidney Outcomes Trial FlOW
Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme
Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme
Novo-Nordisk A/S | 6-K: Notice for the Annual General Meeting of Novo Nordisk A/S
Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme
Novo-Nordisk A/S | 6-K: Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons
Analysis
Price Target
No Data
